Tower Research Capital (TRC)’s Lixte Biotechnology LIXT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.02K | Buy |
+3,332
| New | +$3.02K | ﹤0.01% | 4566 |
|
|
2025
Q1 | – | Sell |
-681
| Closed | -$1.38K | – | 5536 |
|
|
2024
Q4 | $1.38K | Sell |
681
-1,429
| -68% | -$2.9K | ﹤0.01% | 5033 |
|
|
2024
Q3 | $3.95K | Sell |
2,110
-1,107
| -34% | -$2.07K | ﹤0.01% | 4728 |
|
|
2024
Q2 | $7.62K | Sell |
3,217
-724
| -18% | -$1.72K | ﹤0.01% | 4442 |
|
|
2024
Q1 | $13.3K | Buy |
3,941
+1,702
| +76% | +$5.75K | ﹤0.01% | 3405 |
|
|
2023
Q4 | $5.26K | Buy |
2,239
+1,180
| +111% | +$2.77K | ﹤0.01% | 4860 |
|
|
2023
Q3 | $2.6K | Buy |
1,059
+1,051
| +13,138% | +$2.58K | ﹤0.01% | 5133 |
|
|
2023
Q2 | $47 | Sell |
8
-76
| -90% | -$447 | ﹤0.01% | 5850 |
|
|
2023
Q1 | $1K | Sell |
84
-590
| -88% | -$7.02K | ﹤0.01% | 5571 |
|
|
2022
Q4 | $3K | Sell |
674
-18
| -3% | -$80 | ﹤0.01% | 5205 |
|
|
2022
Q3 | $4K | Buy |
692
+118
| +21% | +$682 | ﹤0.01% | 5266 |
|
|
2022
Q2 | $4K | Buy |
574
+299
| +109% | +$2.08K | ﹤0.01% | 5229 |
|
|
2022
Q1 | $3K | Sell |
275
-96
| -26% | -$1.05K | ﹤0.01% | 5384 |
|
|
2021
Q4 | $4K | Buy |
371
+189
| +104% | +$2.04K | ﹤0.01% | 5323 |
|
|
2021
Q3 | $4K | Buy |
+182
| New | +$4K | ﹤0.01% | 4981 |
|
|
2021
Q2 | – | Sell |
-157
| Closed | -$5K | – | 5679 |
|
|
2021
Q1 | $5K | Buy |
+157
| New | +$5K | ﹤0.01% | 4673 |
|